- Home
- SN vs RVMD Comparison
SN vs RVMD Comparison
Compare SN & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SN | RVMD |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 15.2B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SN | RVMD |
|---|---|---|
| Price | $124.12 | $102.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | ★ $132.88 | $102.63 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.19 | N/A |
| Revenue Next Year | $10.81 | $758.37 |
| P/E Ratio | $25.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.50 | $29.17 |
| 52 Week High | $133.99 | $124.49 |
Technical Indicators
Market Signals| Indicator | SN | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 57.02 |
| Support Level | $111.44 | $92.76 |
| Resistance Level | $128.85 | $124.49 |
| Average True Range (ATR) | 6.33 | 3.19 |
| MACD | 0.32 | 0.08 |
| Stochastic Oscillator | 53.80 | 92.74 |
Price Performance
Historical ComparisonAbout SN SharkNinja Inc.
SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.